Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma
about
Indicators and Qualitative Assessment of Lung Cancer Management by Health Insurance Review and Assessment Service (HIRA) of Korea in 2015.Pemetrexed Continuation Maintenance versus Conventional Platinum-Based Doublet Chemotherapy in EGFR-Negative Lung Adenocarcinoma: Retrospective Analysis.The continued EGFR-TKI with cytotoxic chemotherapy at progression-poison or medicine?
P2860
Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Mechanisms of Epidermal Growth ...... istance in Lung Adenocarcinoma
@ast
Mechanisms of Epidermal Growth ...... istance in Lung Adenocarcinoma
@en
Mechanisms of Epidermal Growth ...... istance in Lung Adenocarcinoma
@nl
type
label
Mechanisms of Epidermal Growth ...... istance in Lung Adenocarcinoma
@ast
Mechanisms of Epidermal Growth ...... istance in Lung Adenocarcinoma
@en
Mechanisms of Epidermal Growth ...... istance in Lung Adenocarcinoma
@nl
prefLabel
Mechanisms of Epidermal Growth ...... istance in Lung Adenocarcinoma
@ast
Mechanisms of Epidermal Growth ...... istance in Lung Adenocarcinoma
@en
Mechanisms of Epidermal Growth ...... istance in Lung Adenocarcinoma
@nl
P2860
P3181
P1476
Mechanisms of Epidermal Growth ...... istance in Lung Adenocarcinoma
@en
P2093
Chang-Min Choi
Jae Cheol Lee
P2860
P304
P3181
P356
10.4046/TRD.2016.79.4.248
P407
P577
2016-10-05T00:00:00Z